世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Autoimmune Diseases Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0522
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、自己免疫疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（輸血、サプリメント、医薬品、理学療法、その他）、用途別市場規模（病院、医療センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・自己免疫疾患治療の市場動向
・企業の競争状況、市場シェア
・自己免疫疾患治療の種類別市場規模（輸血、サプリメント、医薬品、理学療法、その他）
・自己免疫疾患治療の用途別市場規模（病院、医療センター、その他）
・自己免疫疾患治療の北米市場規模2016-2027（アメリカ、カナダ）
・自己免疫疾患治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・自己免疫疾患治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・自己免疫疾患治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・自己免疫疾患治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Abbott Laboratories、Active Biotech、Eli Lilly、AstraZeneca、Lupin、Amgen、Bristol-Myers Squibb、AutoImmune、Pfizer、GlaxoSmithKline、F. Hoffmann-La Roche、Johnson & Johnson）
・結論

Market Analysis and Insights: Global Autoimmune Diseases Treatment Market
The global Autoimmune Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Autoimmune Diseases Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Autoimmune Diseases Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Autoimmune Diseases Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Autoimmune Diseases Treatment market.

Global Autoimmune Diseases Treatment Scope and Market Size
Autoimmune Diseases Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Autoimmune Diseases Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Blood Transfusion
Supplements
Drugs
Physical Therapy
Other

Segment by Application
Hospital
Medical Center
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Active Biotech
Eli Lilly
AstraZeneca
Lupin
Amgen
Bristol-Myers Squibb
AutoImmune
Pfizer
AstraZeneca

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Diseases Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Blood Transfusion
1.2.3 Supplements
1.2.4 Drugs
1.2.5 Physical Therapy
1.2.6 Other
1.3 Market by Application
1.3.1 Global Autoimmune Diseases Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Medical Center
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Autoimmune Diseases Treatment Market Perspective (2016-2027)
2.2 Autoimmune Diseases Treatment Growth Trends by Regions
2.2.1 Autoimmune Diseases Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Autoimmune Diseases Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Autoimmune Diseases Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Autoimmune Diseases Treatment Industry Dynamic
2.3.1 Autoimmune Diseases Treatment Market Trends
2.3.2 Autoimmune Diseases Treatment Market Drivers
2.3.3 Autoimmune Diseases Treatment Market Challenges
2.3.4 Autoimmune Diseases Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Diseases Treatment Players by Revenue
3.1.1 Global Top Autoimmune Diseases Treatment Players by Revenue (2016-2021)
3.1.2 Global Autoimmune Diseases Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Autoimmune Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Diseases Treatment Revenue
3.4 Global Autoimmune Diseases Treatment Market Concentration Ratio
3.4.1 Global Autoimmune Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Diseases Treatment Revenue in 2020
3.5 Autoimmune Diseases Treatment Key Players Head office and Area Served
3.6 Key Players Autoimmune Diseases Treatment Product Solution and Service
3.7 Date of Enter into Autoimmune Diseases Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Autoimmune Diseases Treatment Breakdown Data by Type
4.1 Global Autoimmune Diseases Treatment Historic Market Size by Type (2016-2021)
4.2 Global Autoimmune Diseases Treatment Forecasted Market Size by Type (2022-2027)

5 Autoimmune Diseases Treatment Breakdown Data by Application
5.1 Global Autoimmune Diseases Treatment Historic Market Size by Application (2016-2021)
5.2 Global Autoimmune Diseases Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Autoimmune Diseases Treatment Market Size (2016-2027)
6.2 North America Autoimmune Diseases Treatment Market Size by Type
6.2.1 North America Autoimmune Diseases Treatment Market Size by Type (2016-2021)
6.2.2 North America Autoimmune Diseases Treatment Market Size by Type (2022-2027)
6.2.3 North America Autoimmune Diseases Treatment Market Size by Type (2016-2027)
6.3 North America Autoimmune Diseases Treatment Market Size by Application
6.3.1 North America Autoimmune Diseases Treatment Market Size by Application (2016-2021)
6.3.2 North America Autoimmune Diseases Treatment Market Size by Application (2022-2027)
6.3.3 North America Autoimmune Diseases Treatment Market Size by Application (2016-2027)
6.4 North America Autoimmune Diseases Treatment Market Size by Country
6.4.1 North America Autoimmune Diseases Treatment Market Size by Country (2016-2021)
6.4.2 North America Autoimmune Diseases Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Autoimmune Diseases Treatment Market Size (2016-2027)
7.2 Europe Autoimmune Diseases Treatment Market Size by Type
7.2.1 Europe Autoimmune Diseases Treatment Market Size by Type (2016-2021)
7.2.2 Europe Autoimmune Diseases Treatment Market Size by Type (2022-2027)
7.2.3 Europe Autoimmune Diseases Treatment Market Size by Type (2016-2027)
7.3 Europe Autoimmune Diseases Treatment Market Size by Application
7.3.1 Europe Autoimmune Diseases Treatment Market Size by Application (2016-2021)
7.3.2 Europe Autoimmune Diseases Treatment Market Size by Application (2022-2027)
7.3.3 Europe Autoimmune Diseases Treatment Market Size by Application (2016-2027)
7.4 Europe Autoimmune Diseases Treatment Market Size by Country
7.4.1 Europe Autoimmune Diseases Treatment Market Size by Country (2016-2021)
7.4.2 Europe Autoimmune Diseases Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Diseases Treatment Market Size (2016-2027)
8.2 Asia-Pacific Autoimmune Diseases Treatment Market Size by Type
8.2.1 Asia-Pacific Autoimmune Diseases Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Autoimmune Diseases Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Autoimmune Diseases Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Autoimmune Diseases Treatment Market Size by Application
8.3.1 Asia-Pacific Autoimmune Diseases Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Autoimmune Diseases Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Autoimmune Diseases Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Autoimmune Diseases Treatment Market Size by Region
8.4.1 Asia-Pacific Autoimmune Diseases Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Autoimmune Diseases Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Autoimmune Diseases Treatment Market Size (2016-2027)
9.2 Latin America Autoimmune Diseases Treatment Market Size by Type
9.2.1 Latin America Autoimmune Diseases Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Autoimmune Diseases Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Autoimmune Diseases Treatment Market Size by Type (2016-2027)
9.3 Latin America Autoimmune Diseases Treatment Market Size by Application
9.3.1 Latin America Autoimmune Diseases Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Autoimmune Diseases Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Autoimmune Diseases Treatment Market Size by Application (2016-2027)
9.4 Latin America Autoimmune Diseases Treatment Market Size by Country
9.4.1 Latin America Autoimmune Diseases Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Autoimmune Diseases Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Diseases Treatment Market Size (2016-2027)
10.2 Middle East & Africa Autoimmune Diseases Treatment Market Size by Type
10.2.1 Middle East & Africa Autoimmune Diseases Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Autoimmune Diseases Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Autoimmune Diseases Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Autoimmune Diseases Treatment Market Size by Application
10.3.1 Middle East & Africa Autoimmune Diseases Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Autoimmune Diseases Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Autoimmune Diseases Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Autoimmune Diseases Treatment Market Size by Country
10.4.1 Middle East & Africa Autoimmune Diseases Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Autoimmune Diseases Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Autoimmune Diseases Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Autoimmune Diseases Treatment Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Active Biotech
11.2.1 Active Biotech Company Details
11.2.2 Active Biotech Business Overview
11.2.3 Active Biotech Autoimmune Diseases Treatment Introduction
11.2.4 Active Biotech Revenue in Autoimmune Diseases Treatment Business (2016-2021)
11.2.5 Active Biotech Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Autoimmune Diseases Treatment Introduction
11.3.4 Eli Lilly Revenue in Autoimmune Diseases Treatment Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Autoimmune Diseases Treatment Introduction
11.4.4 AstraZeneca Revenue in Autoimmune Diseases Treatment Business (2016-2021)
11.4.5 AstraZeneca Recent Development
11.5 Lupin
11.5.1 Lupin Company Details
11.5.2 Lupin Business Overview
11.5.3 Lupin Autoimmune Diseases Treatment Introduction
11.5.4 Lupin Revenue in Autoimmune Diseases Treatment Business (2016-2021)
11.5.5 Lupin Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Autoimmune Diseases Treatment Introduction
11.6.4 Amgen Revenue in Autoimmune Diseases Treatment Business (2016-2021)
11.6.5 Amgen Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Autoimmune Diseases Treatment Introduction
11.7.4 Bristol-Myers Squibb Revenue in Autoimmune Diseases Treatment Business (2016-2021)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 AutoImmune
11.8.1 AutoImmune Company Details
11.8.2 AutoImmune Business Overview
11.8.3 AutoImmune Autoimmune Diseases Treatment Introduction
11.8.4 AutoImmune Revenue in Autoimmune Diseases Treatment Business (2016-2021)
11.8.5 AutoImmune Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Autoimmune Diseases Treatment Introduction
11.9.4 Pfizer Revenue in Autoimmune Diseases Treatment Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Details
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Autoimmune Diseases Treatment Introduction
11.10.4 GlaxoSmithKline Revenue in Autoimmune Diseases Treatment Business (2016-2021)
11.10.5 GlaxoSmithKline Recent Development
11.11 F. Hoffmann-La Roche
11.11.1 F. Hoffmann-La Roche Company Details
11.11.2 F. Hoffmann-La Roche Business Overview
11.11.3 F. Hoffmann-La Roche Autoimmune Diseases Treatment Introduction
11.11.4 F. Hoffmann-La Roche Revenue in Autoimmune Diseases Treatment Business (2016-2021)
11.11.5 F. Hoffmann-La Roche Recent Development
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Details
11.12.2 Johnson & Johnson Business Overview
11.12.3 Johnson & Johnson Autoimmune Diseases Treatment Introduction
11.12.4 Johnson & Johnson Revenue in Autoimmune Diseases Treatment Business (2016-2021)
11.12.5 Johnson & Johnson Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Autoimmune Diseases Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Blood Transfusion
Table 3. Key Players of Supplements
Table 4. Key Players of Drugs
Table 5. Key Players of Physical Therapy
Table 6. Key Players of Other
Table 7. Global Autoimmune Diseases Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Autoimmune Diseases Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Autoimmune Diseases Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Autoimmune Diseases Treatment Market Share by Regions (2016-2021)
Table 11. Global Autoimmune Diseases Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Autoimmune Diseases Treatment Market Share by Regions (2022-2027)
Table 13. Autoimmune Diseases Treatment Market Trends
Table 14. Autoimmune Diseases Treatment Market Drivers
Table 15. Autoimmune Diseases Treatment Market Challenges
Table 16. Autoimmune Diseases Treatment Market Restraints
Table 17. Global Autoimmune Diseases Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Autoimmune Diseases Treatment Market Share by Players (2016-2021)
Table 19. Global Top Autoimmune Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Diseases Treatment as of 2020)
Table 20. Ranking of Global Top Autoimmune Diseases Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Autoimmune Diseases Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Autoimmune Diseases Treatment Product Solution and Service
Table 24. Date of Enter into Autoimmune Diseases Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Autoimmune Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Autoimmune Diseases Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Autoimmune Diseases Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Autoimmune Diseases Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Autoimmune Diseases Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Autoimmune Diseases Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Autoimmune Diseases Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Autoimmune Diseases Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Autoimmune Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Autoimmune Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Autoimmune Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Autoimmune Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Autoimmune Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Autoimmune Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Autoimmune Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Autoimmune Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Autoimmune Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Autoimmune Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Autoimmune Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Autoimmune Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Autoimmune Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Autoimmune Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Autoimmune Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Autoimmune Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Autoimmune Diseases Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Autoimmune Diseases Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Autoimmune Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Autoimmune Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Autoimmune Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Autoimmune Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Autoimmune Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Autoimmune Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Autoimmune Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Autoimmune Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Autoimmune Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Autoimmune Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Autoimmune Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Autoimmune Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Laboratories Company Details
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Autoimmune Diseases Treatment Product
Table 67. Abbott Laboratories Revenue in Autoimmune Diseases Treatment Business (2016-2021) & (US$ Million)
Table 68. Abbott Laboratories Recent Development
Table 69. Active Biotech Company Details
Table 70. Active Biotech Business Overview
Table 71. Active Biotech Autoimmune Diseases Treatment Product
Table 72. Active Biotech Revenue in Autoimmune Diseases Treatment Business (2016-2021) & (US$ Million)
Table 73. Active Biotech Recent Development
Table 74. Eli Lilly Company Details
Table 75. Eli Lilly Business Overview
Table 76. Eli Lilly Autoimmune Diseases Treatment Product
Table 77. Eli Lilly Revenue in Autoimmune Diseases Treatment Business (2016-2021) & (US$ Million)
Table 78. Eli Lilly Recent Development
Table 79. AstraZeneca Company Details
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca Autoimmune Diseases Treatment Product
Table 82. AstraZeneca Revenue in Autoimmune Diseases Treatment Business (2016-2021) & (US$ Million)
Table 83. AstraZeneca Recent Development
Table 84. Lupin Company Details
Table 85. Lupin Business Overview
Table 86. Lupin Autoimmune Diseases Treatment Product
Table 87. Lupin Revenue in Autoimmune Diseases Treatment Business (2016-2021) & (US$ Million)
Table 88. Lupin Recent Development
Table 89. Amgen Company Details
Table 90. Amgen Business Overview
Table 91. Amgen Autoimmune Diseases Treatment Product
Table 92. Amgen Revenue in Autoimmune Diseases Treatment Business (2016-2021) & (US$ Million)
Table 93. Amgen Recent Development
Table 94. Bristol-Myers Squibb Company Details
Table 95. Bristol-Myers Squibb Business Overview
Table 96. Bristol-Myers Squibb Autoimmune Diseases Treatment Product
Table 97. Bristol-Myers Squibb Revenue in Autoimmune Diseases Treatment Business (2016-2021) & (US$ Million)
Table 98. Bristol-Myers Squibb Recent Development
Table 99. AutoImmune Company Details
Table 100. AutoImmune Business Overview
Table 101. AutoImmune Revenue in Autoimmune Diseases Treatment Business (2016-2021) & (US$ Million)
Table 102. AutoImmune Recent Development
Table 103. Pfizer Company Details
Table 104. Pfizer Business Overview
Table 105. Pfizer Autoimmune Diseases Treatment Product
Table 106. Pfizer Revenue in Autoimmune Diseases Treatment Business (2016-2021) & (US$ Million)
Table 107. Pfizer Recent Development
Table 108. GlaxoSmithKline Company Details
Table 109. GlaxoSmithKline Business Overview
Table 110. GlaxoSmithKline Autoimmune Diseases Treatment Product
Table 111. GlaxoSmithKline Revenue in Autoimmune Diseases Treatment Business (2016-2021) & (US$ Million)
Table 112. GlaxoSmithKline Recent Development
Table 113. F. Hoffmann-La Roche Company Details
Table 114. F. Hoffmann-La Roche Business Overview
Table 115. F. Hoffmann-La Roche Autoimmune Diseases Treatment Product
Table 116. F. Hoffmann-La Roche Revenue in Autoimmune Diseases Treatment Business (2016-2021) & (US$ Million)
Table 117. F. Hoffmann-La Roche Recent Development
Table 118. Johnson & Johnson Company Details
Table 119. Johnson & Johnson Business Overview
Table 120. Johnson & Johnson Autoimmune Diseases Treatment Product
Table 121. Johnson & Johnson Revenue in Autoimmune Diseases Treatment Business (2016-2021) & (US$ Million)
Table 122. Johnson & Johnson Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Diseases Treatment Market Share by Type: 2020 VS 2027
Figure 2. Blood Transfusion Features
Figure 3. Supplements Features
Figure 4. Drugs Features
Figure 5. Physical Therapy Features
Figure 6. Other Features
Figure 7. Global Autoimmune Diseases Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Medical Center Case Studies
Figure 10. Other Case Studies
Figure 11. Autoimmune Diseases Treatment Report Years Considered
Figure 12. Global Autoimmune Diseases Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Autoimmune Diseases Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Autoimmune Diseases Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Autoimmune Diseases Treatment Market Share by Regions (2022-2027)
Figure 16. Global Autoimmune Diseases Treatment Market Share by Players in 2020
Figure 17. Global Top Autoimmune Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Diseases Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Autoimmune Diseases Treatment Revenue in 2020
Figure 19. Global Autoimmune Diseases Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Autoimmune Diseases Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Autoimmune Diseases Treatment Market Share by Type (2016-2027)
Figure 23. North America Autoimmune Diseases Treatment Market Share by Application (2016-2027)
Figure 24. North America Autoimmune Diseases Treatment Market Share by Country (2016-2027)
Figure 25. United States Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Autoimmune Diseases Treatment Market Share by Type (2016-2027)
Figure 29. Europe Autoimmune Diseases Treatment Market Share by Application (2016-2027)
Figure 30. Europe Autoimmune Diseases Treatment Market Share by Country (2016-2027)
Figure 31. Germany Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Autoimmune Diseases Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Autoimmune Diseases Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Autoimmune Diseases Treatment Market Share by Region (2016-2027)
Figure 41. China Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Autoimmune Diseases Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Autoimmune Diseases Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Autoimmune Diseases Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Autoimmune Diseases Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Autoimmune Diseases Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Autoimmune Diseases Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Autoimmune Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abbott Laboratories Revenue Growth Rate in Autoimmune Diseases Treatment Business (2016-2021)
Figure 61. Active Biotech Revenue Growth Rate in Autoimmune Diseases Treatment Business (2016-2021)
Figure 62. Eli Lilly Revenue Growth Rate in Autoimmune Diseases Treatment Business (2016-2021)
Figure 63. AstraZeneca Revenue Growth Rate in Autoimmune Diseases Treatment Business (2016-2021)
Figure 64. Lupin Revenue Growth Rate in Autoimmune Diseases Treatment Business (2016-2021)
Figure 65. Amgen Revenue Growth Rate in Autoimmune Diseases Treatment Business (2016-2021)
Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Autoimmune Diseases Treatment Business (2016-2021)
Figure 67. AutoImmune Revenue Growth Rate in Autoimmune Diseases Treatment Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Autoimmune Diseases Treatment Business (2016-2021)
Figure 69. GlaxoSmithKline Revenue Growth Rate in Autoimmune Diseases Treatment Business (2016-2021)
Figure 70. F. Hoffmann-La Roche Revenue Growth Rate in Autoimmune Diseases Treatment Business (2016-2021)
Figure 71. Johnson & Johnson Revenue Growth Rate in Autoimmune Diseases Treatment Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介

世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年）

Global Autoimmune Disorders Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0523 2021年4月 91Pages
QYResearch社発行の本調査資料では、自己免疫疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ブリッジ療法、組換え技術、糞便細菌療法、造血幹細胞移植、光線療法、寄生虫療法、活性化誘導アッセイ、飛行時間型質量分析サイトメトリー）、用...

世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年）

Global Autoimmune Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0521 2021年4月 125Pages
QYResearch社発行の本調査資料では、自己免疫疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制剤、抗炎症薬、コルチコステロイド、非ステロイド性抗炎症薬、生物製剤）、用途別市場規模（病院、クリニック、ドラッグストア、その他）...

世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年）

Global Autoimmune Disease Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z0520 2021年4月 93Pages
QYResearch社発行の本調査資料では、自己免疫疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制剤、抗炎症薬、コルチコステロイド、非ステロイド性抗炎症薬、生物製剤、その他）、用途別市場規模（病院、クリニック、独立型薬局、その...

世界の動物用自己免疫疾患検査市場規模・現状・予測（2021年-2027年）

Global Animal Autoimmune Diseases Testing Market Size, Status and Forecast 2021-2027
QYR2104Z0333 2021年4月 93Pages
QYResearch社発行の本調査資料では、動物用自己免疫疾患検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗核抗体検査、クーム検査、エリテマトーデス細胞検査、蛍光抗体検査、凝固検査、その他）、用途別市場規模（コンパニオンアニマル、家畜動...

世界の動物用自己免疫疾患検査市場規模・現状・予測（2021年-2027年）

世界の自己免疫疾患用体外診断用医薬品（IVD）・薬事未承認検査市場規模・現状・予測（2021年-2027年）

Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size, Status and Forecast 2021-2027
QYR2104Z3067 2021年4月 92Pages
QYResearch社発行の本調査資料では、自己免疫疾患用体外診断用医薬品（IVD）・薬事未承認検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（試薬・キット、機器、サービス、データ管理ソフトウェア）、用途別市場規模（糖尿病、感染症、腫瘍・癌...

世界の感染性疾患治療市場規模・現状・予測（2021年-2027年）

Global Communicable Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1490 2021年4月 93Pages
QYResearch社発行の本調査資料では、感染性疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（HIV、インフルエンザ、結核、マラリア、肝炎、HPV）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨ...

世界の伝染病治療市場規模・現状・予測（2021年-2027年）

Global Treatment for Communicable Diseases Market Size, Status and Forecast 2021-2027
QYR2104Z5738 2021年4月 96Pages
QYResearch社発行の本調査資料では、伝染病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（HIV、インフルエンザ、結核、マラリア、肝炎、HPV）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の孤児肺疾患治療市場規模・現状・予測（2021年-2027年）

Global Orphan Lung Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4327 2021年4月 92Pages
QYResearch社発行の本調査資料では、孤児肺疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制剤、抗炎症剤、抗線維化剤、血管拡張剤、コルチコステロイド、CFTRモジュレーター、その他）、用途別市場規模（病院薬局、ドラッグスト...

世界の運動ニューロン病治療市場規模・現状・予測（2021年-2027年）

Global Motor Neuron Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3924 2021年4月 94Pages
QYResearch社発行の本調査資料では、運動ニューロン病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（リルゾール、ヌシネルセン、理学療法、呼吸療法、その他）、用途別市場規模（総合クリニック、病院、社会福祉施設、その他）、主要地域別市場...

世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年） Graves' disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence of autoimmune diseases is high in women than in men, which results from the influence of estrogen on i…
世界の動物用自己免疫疾患検査市場規模・現状・予測（2021年-2027年） Animal autoimmune diseases are the result of specific immune responses and directed against self. Animals have the ability to control immune aggression. It acquired the capacity to avoid self-reaction called as tolerance, which allows removal of antigenic pathogens in the absence of self-recognition…
世界の動物用自己免疫疾患検査市場規模・現状・予測（2021年-2027年） Animal autoimmune diseases are the result of specific immune responses and directed against self. Animals have the ability to control immune aggression. It acquired the capacity to avoid self-reaction called as tolerance, which allows removal of antigenic pathogens in the absence of self-recognition…
世界の自己免疫疾患用体外診断用医薬品（IVD）・薬事未承認検査市場規模・現状・予測（2021年-2027年） In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.LDT for autoimmune diseases are tests specially developed in laboratory testing some autoimmune diseases. The market growth is attributed to rising occurren…
世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年） Autoimmune diseases is a body’s hyperactive immune response against the substances and tissues normally present in the body. Autoimmune diseases are more commonly caused by genetic, infectious or environmental factors. Market Analysis and Insights: Global Autoimmune Disease Treatment Market The glob…